Table S4.
Severity | Adverse Event | No. subjects with event |
---|---|---|
Mild | Skin irritation (soreness, itchiness) | 3 |
Mild | Nausea/vomiting | 1 |
Mild | Tongue soreness | 1 |
Mild | Pain or discomfort due to electrical stimulation | 1 |
Mild | Change in salivary flow | 1 |
Mild | Tongue abrasion with or without visible lesion(s) | 4 |
Total with at least 1 mild adverse event | 9/21 | |
Moderate | Pain | 1 |
Moderate | Tongue muscle fatigue, weakness or soreness | 3 |
Moderate | Tongue abrasion with or without visible lesion(s) | 8 |
Moderate | Bruising | 1 |
Moderate | Lip Weakness | 1 |
Moderate | Genitourinary abnormality | 1 |
Moderate | Abnormal scarring (keloid or hypertrophic) | 1 |
Moderate | Musculoskeletal abnormality | 1 |
Total with at least 1 moderate adverse event | 9/21 | |
Severe | Infection* | 1 |
Severe | Cuff dislodgement* | 1 |
Total with at least 1 severe adverse event | 2/21 |
Adverse events determined by the Clinical Events Committee to be related to HGNS therapy. Totals refer to number of patients with an event (i.e., one subject may have had > 1 event of a given severity).
Serious adverse event, also considered to be related to the implant procedure.